Atea Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/11/2026

1. SKHY
2. USO
3. SPY
4. META
5. DAL
6. PEP
7. SKHYV
8. ALP
9. NRIX
10. KBH

Go back to Atea Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update

Aviragen Therapeutics (AVIR) Tops Q2 EPS by 11c

August 8, 2022 4:34 PM EDT

Aviragen Therapeutics (NASDAQ: AVIR) reported Q2 EPS of ($0.38), $0.11 better than the analyst estimate of ($0.49).

For earnings history and earnings-related data on Aviragen Therapeutics (AVIR) click here.

... More